Division of Pharmacology, Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, Jharkhand, 835215, India.
Government Pharmacy Institute, Govt. of Jharkhand, Bariatu, Ranchi, Jharkhand, 834009, India.
Curr Microbiol. 2021 Nov;78(11):3813-3828. doi: 10.1007/s00284-021-02657-9. Epub 2021 Sep 22.
COVID-19, a type of viral pneumonia caused by severe acute respiratory syndrome coronavirus 2 has challenged the world as global pandemic. It has marked the identification of third generation of extremely pathogenic zoonotic coronaviruses of twenty-first century posing threat to humans and mainly targeting the lower respiratory tract. In this review, we focused on not only the structure and virology of SARS-COV-2 but have discussed in detail the molecular immunopathogenesis of this novel virus highlighting its interaction with immune system and the role of compromised or dysregulated immune response towards disease severity. We attempted to correlate the crosstalk between unregulated inflammatory outcomes with disrupted host immunity which may play a potential role towards fatal acute respiratory distress syndrome that claims to be life-threatening in COVID-19. Exploration and investigation of molecular host-virus interactions will provide a better understanding on the mechanism of fatal COVID-19 infection and also enlighten the escape routes from the same.
新型冠状病毒肺炎(COVID-19)是由严重急性呼吸综合征冠状病毒 2 引起的一种病毒性肺炎,已在全球范围内构成大流行挑战。这标志着 21 世纪第三代高致病性人畜共患冠状病毒的出现,对人类构成威胁,主要攻击下呼吸道。在这篇综述中,我们不仅关注了 SARS-COV-2 的结构和病毒学特性,还详细讨论了这种新型病毒的分子免疫发病机制,强调了其与免疫系统的相互作用以及免疫功能受损或失调对疾病严重程度的作用。我们试图将不受调节的炎症结果与宿主免疫破坏之间的相互作用进行关联,这可能在导致致命性急性呼吸窘迫综合征方面发挥作用,而急性呼吸窘迫综合征在 COVID-19 中被认为是危及生命的。对分子宿主-病毒相互作用的探索和研究将有助于更好地了解致命性 COVID-19 感染的机制,并为逃避感染提供思路。